Etsuko Aoki

544 total citations
16 papers, 364 citations indexed

About

Etsuko Aoki is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Etsuko Aoki has authored 16 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Etsuko Aoki's work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Etsuko Aoki is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Etsuko Aoki collaborates with scholars based in United States, Japan and Vietnam. Etsuko Aoki's co-authors include Yasuhiro Oki, Jean‐Pierre J. Issa, Guillermo Garcia‐Manero, Haruhiko Ohashi, Hidehiko Saito, Toshiki Uchida, T Hotta, Takashi Murate, T. Kinoshita and Carmen P. Escalante and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Etsuko Aoki

15 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Etsuko Aoki United States 8 174 136 86 58 54 16 364
Sayoko Doisaki Japan 12 117 0.7× 182 1.3× 98 1.1× 90 1.6× 51 0.9× 28 387
Daiki Karigane Japan 10 128 0.7× 140 1.0× 54 0.6× 80 1.4× 50 0.9× 31 337
Amine Belhabri France 14 147 0.8× 272 2.0× 112 1.3× 33 0.6× 95 1.8× 40 458
Tomoo Osumi Japan 11 110 0.6× 90 0.7× 35 0.4× 40 0.7× 104 1.9× 54 374
Amber C. King United States 11 157 0.9× 204 1.5× 108 1.3× 26 0.4× 117 2.2× 31 419
Katarzyna Kapelko‐Słowik Poland 11 94 0.5× 84 0.6× 45 0.5× 85 1.5× 78 1.4× 25 336
Kentaro Yoshinaga Japan 13 67 0.4× 130 1.0× 90 1.0× 73 1.3× 70 1.3× 48 382
Juan Manuel Alonso‐Domínguez Spain 10 78 0.4× 106 0.8× 75 0.9× 30 0.5× 58 1.1× 40 242
Anna Staffas Sweden 11 226 1.3× 208 1.5× 33 0.4× 76 1.3× 76 1.4× 25 434
Sigrid Machherndl‐Spandl Austria 8 87 0.5× 159 1.2× 63 0.7× 35 0.6× 38 0.7× 36 248

Countries citing papers authored by Etsuko Aoki

Since Specialization
Citations

This map shows the geographic impact of Etsuko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuko Aoki more than expected).

Fields of papers citing papers by Etsuko Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuko Aoki. The network helps show where Etsuko Aoki may publish in the future.

Co-authorship network of co-authors of Etsuko Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Etsuko Aoki. A scholar is included among the top collaborators of Etsuko Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuko Aoki. Etsuko Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Maese, Luke, Mignon L. Loh, Mi Rim Choi, et al.. (2024). Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children’s Oncology Group AALL1931 study. Blood Advances. 9(1). 66–77.
2.
3.
Maese, Luke, Mignon L. Loh, Leslie Choi, et al.. (2022). Efficacy and safety of intramuscular (IM) recombinant Erwinia asparaginase in acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL): The Children’s Oncology Group (COG) AALL1931 study.. Journal of Clinical Oncology. 40(16_suppl). 7001–7001. 1 indexed citations
4.
Maese, Luke, Mignon L. Loh, Mi Rim Choi, et al.. (2022). Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study. Blood. 141(7). 704–712. 18 indexed citations
5.
6.
7.
8.
Jain, Preetesh, Etsuko Aoki, Michael J. Keating, et al.. (2017). Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). Annals of Oncology. 28(7). 1554–1559. 40 indexed citations
9.
Aoki, Etsuko, Preetesh Jain, Alessandra Ferrajoli, et al.. (2016). Characteristics, Outcomes and Treatment of Patients with T-Cell Prolymphocytic Leukemia (T-PLL) - Single-Center Experience. Blood. 128(22). 2997–2997. 1 indexed citations
10.
Sato, Hitoshi, Seiji Kageyama, Hiroshi Yamamoto, et al.. (2011). Glycyrrhizin renders cells resistant to apoptosis induced by human and feline immunodeficiency virus. 28(3). 139–148. 2 indexed citations
11.
Suzuki, Masahiro, Kazuhiro Yamada, Miki Nagao, et al.. (2011). Antimicrobial Ointments and Methicillin-ResistantStaphylococcus aureusUSA300. Emerging infectious diseases. 17(10). 1917–1920. 22 indexed citations
12.
Oki, Yasuhiro, Etsuko Aoki, & Jean‐Pierre J. Issa. (2006). Decitabine—Bedside to bench. Critical Reviews in Oncology/Hematology. 61(2). 140–152. 125 indexed citations
13.
Aoki, Etsuko, Hagop M. Kantarjian, Stephen J. O’Brien, et al.. (2006). High-dose imatinib mesylate treatment in patients (Pts) with untreated early chronic phase (CP) chronic myeloid leukemia (CML): 2.5-year follow-up. Journal of Clinical Oncology. 24(18_suppl). 6535–6535. 29 indexed citations
14.
Aoki, Etsuko, Hagop M. Kantarjian, Susan O’Brien, et al.. (2005). Correlation of Different Responses to Imatinib on Survival of Patients (pts) with Chronic Myelogenous Leukemia (CML) in Accelerated (AP) and Blast Phase (BP).. Blood. 106(11). 1103–1103. 3 indexed citations
15.
Uchida, Toshiki, Haruhiko Ohashi, Etsuko Aoki, et al.. (2000). Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP). Leukemia. 14(1). 207–212. 31 indexed citations
16.
Aoki, Etsuko, Toshiki Uchida, Haruhiko Ohashi, et al.. (2000). Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes. Leukemia. 14(4). 586–593. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sayoko Doisaki Breakdown of academic impact, for papers by Daiki Karigane Breakdown of academic impact, for papers by Amine Belhabri Breakdown of academic impact, for papers by Tomoo Osumi Breakdown of academic impact, for papers by Amber C. King Breakdown of academic impact, for papers by Katarzyna Kapelko‐Słowik Breakdown of academic impact, for papers by Kentaro Yoshinaga Breakdown of academic impact, for papers by Juan Manuel Alonso‐Domínguez Breakdown of academic impact, for papers by Anna Staffas Breakdown of academic impact, for papers by Sigrid Machherndl‐Spandl
Rankless by CCL
2026